# E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs Questions and Answers (R3) Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/e14-clinical-evaluation-of-qtqtc-interval-prolongation-and-proarrhythmic-potential-for-non-antiarrhythmic-drugs-questions-and-answers-r3-guidance-for-industry/6bec247e-a472-41b1-83c1-27ce44ad427a

> FDA guidance document: E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs Questions and Answers (R3) Guidance for Industry. Issue date: June 28, 2017. Get complete insights and analysis.

---

## Details

- Title: E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs Questions and Answers (R3) Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2017-06-28
- Last Changed: 2025-02-03
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2004-D-0241">FDA-2004-D-0241</a>

## Related Documents

- [E14 and S7B Clinical and Nonclinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential--Questions and Answers :  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/e14-and-s7b-clinical-and-nonclinical-evaluation-of-qtqtc-interval-prolongation-and-proarrhythmic-potential-questions-and-answers-guidance-for-industry/c6214e5a-c9e4-4ba4-9685-598dee7a9985)
- [Expanded Access to Investigational Drugs for Treatment Use - Questions and Answers:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/expanded-access-to-investigational-drugs-for-treatment-use-questions-and-answers-guidance-for-industry/12e2fbc0-e56f-4be2-8fa3-278d7a366326)
- [E2C(R2) Periodic Benefit-Risk Evaluation Report – Questions and Answers](https://www.globalkeysolutions.net/guidances/guidance-document/e2cr2-periodic-benefit-risk-evaluation-report-questions-and-answers/9735c0c5-468e-4e9b-a4c9-a7bad1eb9d94)